# Inhibrx Biosciences, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/inhibrx-biosciences-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-18T07:12:02.527648+00:00 | | Last reviewed | 2026-10-18T07:12:02.527648+00:00 | ## Identity - Legal name: Inhibrx Biosciences, Inc. - Display name: Inhibrx Biosciences, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-18T16:52:02.683999+00:00 | | Completeness | 0.409 | | Record Quality | 0.826 | | Directors | 7 | | Committees | 1 | | Governance events | 6 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - David J. Matly: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-23. claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:6 - Douglas G. Forsyth: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC (chair). claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:7 - Jon Faiz Kayyem: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC (member). claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:8 - Kelly D. Deck: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-23. claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:9 - Kimberly Manhard: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:10 - Kristiina Vuori: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. Committees: AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC (member). claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:11 - Mark P. Lappe: Chief Executive Officer and Chairman of the Board of Directors. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:5 ## Committees - AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC (audit). Chair: Douglas G. Forsyth. Members: Douglas G. Forsyth (chair, current); Jon Faiz Kayyem (member, current); Kristiina Vuori (member, current). committee_id=alpha:committee:inhibrx-biosciences-inc:audit-committee-of-the-board-of-directors-of-inhibrx-biosciences-inc ## Executive leadership - David J. Matly: President [PRESIDENT]. Status: unknown. claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:12 - Kelly D. Deck: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:13 - Mark P. Lappe: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:14 ## Governance events - DIRECTOR_APPOINTED: David J. Matly seat on Inhibrx Biosciences, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:akay1l9keb9 - DIRECTOR_APPOINTED: Kelly D. Deck seat on Inhibrx Biosciences, Inc., effective 2026-04-23. Effective: 2026-04-23. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1qndr0qpyre4q - DIRECTOR_APPOINTED: Douglas G. Forsyth seat on Inhibrx Biosciences, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:2mav5b1ft9kzv - DIRECTOR_APPOINTED: Jon Faiz Kayyem seat on Inhibrx Biosciences, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:i0uzry1g6a32g - DIRECTOR_APPOINTED: Kimberly Manhard seat on Inhibrx Biosciences, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:1ehf3gf19cpagh - DIRECTOR_APPOINTED: Kristiina Vuori seat on Inhibrx Biosciences, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-18T07:12:02.527648+00:00. event_id=alpha:event:transition:58ea8u1g12peo ## Scoped resources - `alpha://company/inhibrx-biosciences-inc` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record - `alpha://company/inhibrx-biosciences-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=identity - `alpha://company/inhibrx-biosciences-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=corporate-structure - `alpha://company/inhibrx-biosciences-inc/board` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=board - `alpha://company/inhibrx-biosciences-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=committees - `alpha://company/inhibrx-biosciences-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=leadership - `alpha://company/inhibrx-biosciences-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=ownership - `alpha://company/inhibrx-biosciences-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=financials - `alpha://company/inhibrx-biosciences-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=capital-structure - `alpha://company/inhibrx-biosciences-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=compensation - `alpha://company/inhibrx-biosciences-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=governance - `alpha://company/inhibrx-biosciences-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=shareholder-governance - `alpha://company/inhibrx-biosciences-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=audit - `alpha://company/inhibrx-biosciences-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=legal - `alpha://company/inhibrx-biosciences-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=risk - `alpha://company/inhibrx-biosciences-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=cyber - `alpha://company/inhibrx-biosciences-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=ai-governance - `alpha://company/inhibrx-biosciences-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=agents - `alpha://company/inhibrx-biosciences-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=ecosystem - `alpha://company/inhibrx-biosciences-inc/events` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=events - `alpha://company/inhibrx-biosciences-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=relationships - `alpha://company/inhibrx-biosciences-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=assessments - `alpha://company/inhibrx-biosciences-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:committee_appointment:16: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:douglas-g-forsyth-inbx","name":"Douglas G. Forsyth"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:committee_appointment:17: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC","category":"audit","role":"member","person":{"alpha_id":"alpha:person:jon-faiz-kayyem-inbx","name":"Jon Faiz Kayyem"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:committee_appointment:18: `{"kind":"committee_appointment","original_name":"AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC","category":"audit","role":"member","person":{"alpha_id":"alpha:person:kristiina-vuori-inbx","name":"Kristiina Vuori"},"source_id":"governance_people_committees"}` ## Leadership - Mark P. Lappe: Chief Executive Officer and Chairman of the Board of Directors. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fe52fa983c44e508a359d47f1c81a54850f25aadbb2fcfbae7349b169989cc7. - David J. Matly: Director. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:6. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4b0c0757c9696882c914da95854ba67319550c4adfbd126a9d43af7a0b70284. - Douglas G. Forsyth: Director. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:7. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4b0c0757c9696882c914da95854ba67319550c4adfbd126a9d43af7a0b70284. - Jon Faiz Kayyem: Director. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4b0c0757c9696882c914da95854ba67319550c4adfbd126a9d43af7a0b70284. - Kelly D. Deck: Director. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:9. Valid from: 2026-04-23. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4b0c0757c9696882c914da95854ba67319550c4adfbd126a9d43af7a0b70284. - Kimberly Manhard: Director. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:10. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4b0c0757c9696882c914da95854ba67319550c4adfbd126a9d43af7a0b70284. - Kristiina Vuori: Director. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:11. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a4b0c0757c9696882c914da95854ba67319550c4adfbd126a9d43af7a0b70284. - David J. Matly: President. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fe52fa983c44e508a359d47f1c81a54850f25aadbb2fcfbae7349b169989cc7. - Kelly D. Deck: Chief Financial Officer. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fe52fa983c44e508a359d47f1c81a54850f25aadbb2fcfbae7349b169989cc7. - Mark P. Lappe: Chief Executive Officer. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2fe52fa983c44e508a359d47f1c81a54850f25aadbb2fcfbae7349b169989cc7. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC: Chair Douglas G. Forsyth; Members Douglas G. Forsyth (Chair); Jon Faiz Kayyem; Kristiina Vuori. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1d06c9d0f3264f70d54c3eb06fe821efd567dcd2939b9e154e5d736de731c01f. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Inhibrx Biosciences, Inc.. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4fc2b9dd316894a4d9e3b9737eac82f02d1b63ba84149f870f325cabeeb3ae52. ## Entity Status - Public listing published. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4fc2b9dd316894a4d9e3b9737eac82f02d1b63ba84149f870f325cabeeb3ae52. ## Published Fact - US. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4fc2b9dd316894a4d9e3b9737eac82f02d1b63ba84149f870f325cabeeb3ae52. ## Committee Appointment - Douglas G. Forsyth: chair, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1d06c9d0f3264f70d54c3eb06fe821efd567dcd2939b9e154e5d736de731c01f. - Jon Faiz Kayyem: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1d06c9d0f3264f70d54c3eb06fe821efd567dcd2939b9e154e5d736de731c01f. - Kristiina Vuori: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC. Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1d06c9d0f3264f70d54c3eb06fe821efd567dcd2939b9e154e5d736de731c01f. ## Security Listing - INBX (NASDAQ). Claim: alpha:claim:company:17db4aa2-ab56-4f17-a2fc-c1fcea34f685:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:4fc2b9dd316894a4d9e3b9737eac82f02d1b63ba84149f870f325cabeeb3ae52. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:4fc2b9dd316894a4d9e3b9737eac82f02d1b63ba84149f870f325cabeeb3ae52: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/inhibrx-biosciences-inc). - alpha:projection-evidence:document:2fe52fa983c44e508a359d47f1c81a54850f25aadbb2fcfbae7349b169989cc7: [SEC DEF 14A 0002007919-26-000014](https://www.sec.gov/Archives/edgar/data/2007919/000200791926000014/inbx-20260422.htm). - alpha:projection-evidence:document:a4b0c0757c9696882c914da95854ba67319550c4adfbd126a9d43af7a0b70284: [DEF 14A inbx-20260422.htm](https://www.sec.gov/Archives/edgar/data/2007919/000200791926000014/inbx-20260422.htm). - alpha:projection-evidence:1d06c9d0f3264f70d54c3eb06fe821efd567dcd2939b9e154e5d736de731c01f: [AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF INHIBRX BIOSCIENCES, INC](https://www.sec.gov/Archives/edgar/data/2007919/000200791926000014/inbx-20260422.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/inhibrx-biosciences-inc) - [Public Markdown](https://registry.alpha.ac/companies/inhibrx-biosciences-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/inhibrx-biosciences-inc?format=jsonld) - MCP resource: `alpha://companies/inhibrx-biosciences-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-18T16:52:02.447654+00:00; recorded 2026-10-18T16:52:02.447654+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.